Results 171 to 180 of about 50,656 (201)
Some of the next articles are maybe not open access.
Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity
2015Obesity is a complex and retractable disease for which effective and durable treatments are elusive. Successful treatment of severe obesity with lifestyle modification therapy alone is highly unlikely, particularly for adolescents. Pharmacotherapy, if appropriately prescribed, can be an effective tool to use in conjunction with lifestyle modification ...
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Glucagon-like Peptide-1 Receptor Agonists (GLP1-RA)
2022Radica Z. Alicic +3 more
openaire +1 more source
Glucagon-Like Peptide-1 Receptor Agonists—How Safe Are They?
JAMA Internal Medicine, 2022Shanzay, Haider, Kasia J, Lipska
openaire +2 more sources
[Glucagon-like peptide-1 receptor agonists].
Nihon rinsho. Japanese journal of clinical medicine, 2012Takeshi, Kurose, Yutaka, Seino
openaire +1 more source
Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery
JAMA SurgeryPhilip M, Jones, Ion A, Hobai
openaire +2 more sources